Healthcare -
Biotechnology - NASDAQ - US
$ 1.5
-1.32 %
$ 22.3 M
Market Cap
-0.27
P/E
LGVN - GROSS PROFIT
Gross Profit LGVN - Longeveron Inc.
221 K
LAST VALUE
-38.80%
2 YEAR CAGR
-20.15%
5 YEAR CAGR
0.00%
10 YEAR CAGR